Comments and Letters

  • Letter to Senators Reid and McConnell Regarding Coinsurance

    July 07, 2011
      The Honorable Harry Reid Majority Leader U.S. Senate 522 Hart Senate Office Building Washington, DC 20510 The Honorable Mitch McConnell Minority Leader U.S. Senate 317 Russell Senate Office Building Washington, DC 20510 Dear Majority Leader Reid and Minority Leader McConnell: The undersigned laboratory and health care organizations, representing America’s community, regional, and national laboratories, their employees, practitioners, and the Medicare patients we serveContinue Reading »...
  • Letter to Representative Don Young Regarding Coinsurance

    June 27, 2011
      June 27, 2011 The Honorable Don Young United States House of Representatives 2314 Rayburn House Office Building Washington, DC 20515 Dear Representative Young: The American Clinical Laboratory Association (ACLA) represents the leading providers of laboratory services in the United States. We are writing to convey our serious concerns about the possible imposition of coinsurance for clinical laboratory services provided under Medicare, as partContinue Reading »...
  • Letter to the Tennessee Medical Laboratory Licensing Board

    June 06, 2011
    Ms. Lynda England, Director Tennessee Medical Laboratory Licensing Board Division of Health Related Boards 227 French Landing, Ste. 300 Heritage Place Metro Center Nashville, Tennessee 37243   Ms. England: On behalf of the American Clinical Laboratory Association, I am writing to seek clarification of the April 15, 2011 policy statement from the Tennessee Medical Laboratory Licensing Board regarding “Patient Test Management/Laboratory Reports” (hereinafter “PolicyContinue Reading »...
  • Comments on the Medicare Shared Savings Program: Accountable Care Organizations Proposed Rule

    June 06, 2011
    The American Clinical Laboratory Association (ACLA) is pleased to have this opportunity to submit our comments on the Medicare Program; Medicare Shared Savings Program: Accountable Care Organizations; Proposed Rule (the “Proposed Rule”).1 ACLA is an association representing clinical laboratories throughout the country, including local, regional, and national laboratories. As providers of clinical diagnostic laboratory services to Medicare beneficiaries, ACLA member companies will be directlyContinue Reading »...
  • Comments on ACO proposed F-A Waivers

    June 06, 2011
    COMMENTS OF THE AMERICAN CLINICAL LABORATORY ASSOCIATION ON THE MEDICARE PROGRAM; WAIVER DESIGNS IN CONNECTION WITH THE MEDICARE SHARED SAVINGS PROGRAM AND THE INNOVATION CENTER; NOTICE WITH COMMENT PERIOD (CMS-1345-NC2) The American Clinical Laboratory Association (ACLA) is pleased to have this opportunity to submit our comments on the Medicare Program: Waiver Designs in Connection with the Medicare Shared Savings Program and the Innovation Center;Continue Reading »...
  • Memorandum in Opposition to New York AB 3551/SB 4660

    June 01, 2011
    MEMORANDUM IN OPPOSITION AB3551/SB4660 (In relation to referrals of patients for health or health related items or services) The American Clinical Laboratory Association (ACLA) opposes AB 3551/SB 4660. ACLA is an association representing clinical laboratories throughout the country, including local, regional and national laboratories, virtually all of which are licensed by New York to provide services to New York residents and several of whichContinue Reading »...
  • Letter to Lawmakers Regarding Physician Payment Reform

    May 11, 2011
    The Honorable Dave Camp Chairman,House Committee on Ways & Means The Honorable Wally Herger Chairman, Subcommittee on Health House Committee on Ways & Means The Honorable Sander Levin Ranking Member, House Committee on Ways & Means The Honorable Pete Stark Ranking Member, Subcommittee on Health House Committee on Ways & Means   Dear Chairmen and Ranking Members: On behalf of the Alliance for IntegrityContinue Reading »...
  • Letter to CMS Regarding Physician Signature Rule

    May 02, 2011
    Jonathan D. Blum Centers for Medicare & Medicaid Services Director, Center for Medicare Management Mail Stop 314G 200 Independence Avenue, S.W. Washington, D.C. 20201 Dear Mr. Blum: On behalf of the American Clinical Laboratory Association (“ACLA”), I am writing to express our appreciation for your assistance with the “physician signature” rule that was included in the 2011 Physician Fee Schedule (PFS) Rule. In thatContinue Reading »...
  • Comments on Genetic Testing Registry Design

    March 21, 2011
    Genetic Testing Registry Staff National Institutes of Health Re: Genetic Testing Registry Draft Data Fields   The American Clinical Laboratory Association (ACLA) appreciates the opportunity to provide comments on the draft Genetic Testing Register (GTR) data fields. ACLA represents national, regional, and local laboratories across the country. Members of ACLA are proud to be at the forefront of delivering innovative genetic tests in partnershipContinue Reading »...
  • Memorandum in Opposition to 2011-2012 Proposed Health Budget

    February 24, 2011
    In effect, DOH has turned the clinical laboratory reference system special revenue account into an unauthorized and unsupervised revenue stream that is limited only by the bounds of the defendant’s [DOH’s] creativity in characterizing the Wadsworth Center’s expenses as attributable to the oversight of the plaintiffs [laboratories]. Decision and Order of Edward A. Sheridan, J.H.O., Albany County Supreme Court, American Association of Bioanalysts v.Continue Reading »...
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17